MAP2K1 and breast carcinoma: Finally, the results revealed that MEK1 inhibitor (when combined with radiation) significantly reduces the migratory potential of MDA-MB-231 breast cancer cells including reduction of miR-221 expression (Figure 3a) and corresponding downstream ZEB1 and uPAR (EMT) marker expression (Figure 4b–d).